UK campus and HealthCare administration at KY Cancer Registry press conference
  • Article
  • Jun 22 2018

The Kentucky Cancer Registry (KCR) has received a $2.6 million contract from the National Cancer Institute (NCI) to continue its participation in the NCI’s Surveillance Epidemiology and End Results (SEER) program.

Recent News

Series Spotlight People Behind Our Research

Why do we want you to meet our researchers?

The scientists and scholars at the University of Kentucky are remarkable people. Some of them have a very personal connection to field they have chosen: a family member battling addiction or disease. Some of them began their journey based on curiosity. A drive to find out why the world works the way it does.

What they all have in common is a passion to ignite progress and partner across fields and with communities to confront, head on, the most profound challenges. Research can do that, and our researchers tell you why and how.

View Series

Podcasts

  • Podcast
  • Feb 01 2018

Hear how William Stoops chose drug abuse research, why mentoring is one of his favorite parts of his job, and why he sees the chance to do NIH-funded research as a privilege.

Videos

    • Jun 6 2018

    Carbon fiber is the material of the future — a next-generation version of aluminum. The good news for Kentucky manufacturers is that one of the leading carbon fiber research and development facilities in the world is located in their backyard, at the UK Center for Applied Energy Research.

    • May 16 2018

    The Office of the Vice President for Research sent Kaylynne Glover and Alexa Johnson to Washington D.C. for “CASE: Catalyzing Advocacy in Science and Engineering.” See what they learned.

    • May 3 2018

    Following in his father’s footsteps, Esias Bedingar came to UK in 2014 from Chad, not knowing any English at all. Since then, he has founded a nonprofit to help eradicate malaria in his home country, conducts research in neurodegenerative diseases, and will graduate with a degree in public health before attending Harvard University this fall.

    • Apr 18 2018

    A team of UK researchers have homed in on a protein, called RIT1, that may act as a master switch in the brain. A new five-year, $2.5 million grant from the National Institutes of Health will help them explore RIT1 as a possible target for treatments to counteract brain injury.